Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
Wednesday, March 10, 2010 - 10:23
in Health & Medicine
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research.
Read the whole article on Science Daily
More from Science Daily
Related
- Quantity vs. quality: Long-term use of bone-building osteoporosis drugsWed, 10 Mar 2010, 8:24:23 EST
- Long-term use of osteoporosis medication associated with increased risk of atypical fracturesTue, 22 Feb 2011, 17:22:20 EST
- New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patientsTue, 14 Sep 2010, 0:42:35 EDT
- IOF and ESCEO position on atypical femoral fractures and long-term bisphosphonate useWed, 24 Nov 2010, 13:37:09 EST
- Taking a break from osteoporosis drugs can protect bonesThu, 18 Nov 2010, 14:53:33 EST